About Contact Us Careers

Meningitis Imaging Market Size & Share, by Component (Imaging Equipment, Radiology Contrast Agents, Software & AI Solutions, Maintenance & Servicing); End user; Imaging Modality; Disease Type, Trade - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2026-2035

  • Report ID: 8126
  • Published Date: Sep 25, 2025
  • Report Format: PDF, PPT

Meningitis Imaging Market Outlook:

Meningitis Imaging Market size was valued at USD 1.6 billion in 2025 and is projected to reach USD 3.6 billion by the end of 2035, rising at a CAGR of 8.8% during the forecast period, i.e., 2026-2035. In 2026, the industry size of meningitis imaging is evaluated at USD 1.7 billion.

The global meningitis imaging market is driven by an increasing patient base, mainly in low- and middle-income nations where bacterial and viral meningitis is a key source of neurological disability. The Meningitis Research Foundation report in 2024 depicts that more than 2.3 million cases of meningitis are reported worldwide in 2021, and nearly 83.02% of the global burden comes from the lower-middle-income countries. In the U.S., the CDC surveillance report depicts that emergency visits due to meningitis-related imaging increased over the past decade in response to increased awareness and policies for early intervention.

The OEC statistics in 2023 depict that the global trade of MRI devices accounted USD 6.2 billion in 2023, up 6.88% compared to 2022. Further, Germany is the leading exporter of MRI devices, accounting for USD 1.79 billion, followed by the U.S. and China. Governments are increasingly interested in regionalizing assembly lines as a way to lower dependence on limited trade partners. In the same year, the leading importer of MRI machines is the Netherlands, importing worth USD 597 million. This demand is surging the supply chains for medical imaging equipment, radiology components, and contrast agents.

Meningitis Imaging Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Growth Drivers

  • Increase in patient registration and disease occurrence: As per the European Centre for Disease Prevention and Control report in April 2024, the region has recorded 110 death cases of invasive meningococcal disease, in 30 EU member states. In Germany, the rising disease burden among patients demands an increase in imaging diagnostics, based on the improvement in reporting and access to primary care. Further, North America shows a significant growth, based on the NLM report in November 2023, with nearly 1.33 cases per 100 000 individuals of bacterial meningitis is occurred requiring for imaging-related meningitis evaluations yearly in the U.S. The rising patient pool continues to fuel the meningitis imaging market demand for scalable neuroimaging infrastructure in inpatient and emergency settings.
  • Import/Export and imaging equipment availability: According to the U.S. International Trade Commission, Japan, Germany, and Netherlands diagnostic imaging system imports increased year-on-year in 2024. Trade growth has been pivotal in regions like Southeast Asia and Sub-Saharan Africa, where the meningitis burden is still high. Shortages of equipment, delays in semiconductors, and increased import duties on imaging parts, however, have surged prices up, with implications for rollout in poor countries. Strategic investment in home-based assembly lines and diversified supply chains will play a critical role in stabilizing supply and reducing diagnostic bottlenecks.
  • Surging out of pocket spending: On average, the U.S. patients spend USD 1,119, based on common wealth fund report in January 2023 in meningitis-based imaging services, mainly MRIs, due to the high deductible health plans. CMS reports have depicted that apart from insurance coverage, diagnostic imaging remains as primary contributor to medical debt in low income households. Further, out of pocket cost for contrast-enhanced MRIs are rising YoY, minimizing access among the underinsured population. These trends focus the need for mobile radiology and cost effective imaging packaging in semi urban and rural areas.

Meningitis Imaging Market Value for MRI Equipment From 2022 to 2025

Year

Value (INR Cr)

2022

1425

2023

1471

2024

1519

2025

1571

Source: Competition Commission of India, August 2024

Annual Meningitis Cases in 2021

Country

Cases

India

421,775

Nigeria

335,986

Pakistan

135,962

Ethiopia

123,077

China

68,619

Brazil

36,541

Source: Meningitis Research Foundation, 2024

Challenges

  • Logistics disparities in emerging nations: The WHO report states that low-income countries in Africa in meningitis imaging centers do not have operational MRI/CT scanners, primarily because of inadequate import infrastructure and the unavailability of spare parts. This hinders dependable device deployment by international manufacturers. Delays in customs clearance and also the unavailability of trained biomedical engineers further hinder affect timely installation and maintenance of equipment. Consequently, many rural hospitals use outdated or mobile diagnostic units, which lowers image quality and diagnostic precision.

Meningitis Imaging Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

8.8%

Base Year Market Size (2025)

USD 1.6 billion

Forecast Year Market Size (2035)

USD 3.6 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Meningitis Imaging Market Segmentation:

Component Segment Analysis

Imaging devices is estimated to have a value share of 46.5% by 2035. This dominance is because continuous investment in the CT and MRI facilities in both high- and middle-income countries in an attempt to facilitate early neurological diagnosis of meningitis as well as its complications. The growth in meningitis imaging is driven by advancements in imaging systems, integration of artificial intelligence for enhanced diagnosis, and rising investments in the healthcare sector. The growth is further driven by bases of installed legacy systems aging and being replaced as part of national digital healthcare programs.

End user Segment Analysis

Hospitals dominate the end-user segment and is propelled by their centralization of diagnostics, ease of use of advanced radiological equipment, and inclusion in national infectious diseases management guidelines. According to the CDC report in May 2025, meningococcal disease incidence escalated dramatically in 2023 and 2024, reporting 503 cases in 2024. These increased trends highlight the significance of meningitis imaging in public health response and clinical diagnosis.

Imaging Modality Segment Analysis

Magnetic resonance imaging is the leading segment in the image modality segment. Magnetic Resonance Imaging (MRI) leads the segment because of its greater sensitivity in examining meningeal inflammation, abscesses, and complications such as hydrocephalus or ventriculitis. U.S. National Library of Medicine highlights the efficiency of MRI in diagnosing early bacterial and viral meningitis when clinical symptoms prove to be ineffective. In addition, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) was allocated a budget of about USD 419.5 million in FY2023, an increase of 2.1% from FY2022, for research on imaging technologies, such as MRI optimization.

Our in-depth analysis of the meningitis imaging market includes the following segments:

Segment

Subsegments

Imaging Modality
  • Computed Tomography (CT)
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Magnetic Resonance Imaging (MRI)
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Positron Emission Tomography (PET)
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Ultrasound
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Nuclear Imaging
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions

End user
  • Hospitals
  • Diagnostic Imaging Centers
  • Academic & Research Institutions

Disease Type
  • Bacterial Meningitis
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Viral Meningitis
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Fungal Meningitis
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions
  • Parasitic Meningitis
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic & Research Institutions

Trade
  • Domestic Procurement
  • Import-Based Assembly
  • Export-Oriented Production

Component
  • Imaging Equipment
  • Radiology Contrast Agents
  • Software & AI Solutions
  • Maintenance & Servicing
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Meningitis Imaging Market - Regional Analysis

North America Market Insights

North America is the dominating region in the meningitis imaging market and is projected to hold share of 36.5% by 2035. The market is driven by early adoption of diagnostics, government support, and tech-enabled healthcare infrastructure. The inclusion of MRI, CT, and PET neuroimaging within emergency rooms, fueled by CDC guidelines for meningitis detection, is a strong growth driver. As per the NLM report in November 2023, 5 cases were found in the U.S. regarding fungal meningitis and have undergone spinal anaesthesia-related surgical procedures. The extensive use of imaging diagnostics in the screening of meningitis also picked up pace in both nations.

The U.S. meningitis imaging market is driven by strong federal investments and a technology-intensive healthcare environment. The CDC and AHRQ extended infectious disease imaging guidelines within hospitals from 2022 to 2024, helping in the diagnosis of early-stage meningitis. The NLM report in November 2023 stated that approximately 4,100 bacterial meningitis cases occur in the US, with an overall incidence of about 1.0 to 1.33 cases per 100,000 people. Viral meningitis cases (enteroviral) number around 75,000 annually, making up over half of all meningitis cases. The rising cases drives the market in the region.

APAC Market Insights

The Asia-Pacific is the fastest-growing region in the meningitis imaging market is anticipated to hold a considerable share by 2035. The market is driven by increasing disease awareness, enhanced healthcare infrastructure, and growing government healthcare budgets. Advances in MRI and CT systems, also in AI-driven diagnostics, are boosting rates of early detection of meningitis. As per the WHO report published in 2025, the common cause of death in the South East Asia region is bacterial meningitis with 23%. Industry leaders are actively investing in R&D on safe and affordable vaccines against meningitis. 

The meningitis imaging market in China is expanding rapidly. The China CDC report in 2025 states that over the past two decades, the total cases of meningococcal meningitis reached 6,431. The burden of meningococcal meningitis remains the same among the people in China. In addition, the report highlights the need for meningococcal disease vaccination and serogroup B meningococcal vaccine development within the region. Additionally, greater availability of diagnostic tests has resulted in earlier meningitis case detection, improved outcomes for the patient, and decreased hospitalization rates.

India’s Electromedical Equipment Import Data from 2020 to 2025

 

FY2020-21

FY2021-22

FY2022-23

FY2023-24

FY2024-25

Electromedical equipment (including ventilators and diagnostic imaging equipment)

3,569

5,441

4,884

5,408

5,284

Surgical Instruments

104

169

210

205

263

Source: Medical Dialogues, April 2025

Europe Market Insights

Europe meningitis imaging market is expected to account for a major share in 2035. Increasing rates of infection, early diagnosis programs, and the funding support by the EU are fueling the market. Improvements in the neuroimaging technologies like MRI and CT-based CSF diagnostics, together with the government's higher investments in digital healthcare infrastructure, are fueling the penetration of the market. with a focus on meningitis. In addition, the ECDC report in April 2024 indicates that almost 1,149 cases of meningococcal disease were recorded, emphasizing the need for advanced meningitis imaging. National health bodies such as the UK NHS, Germany's BMG, and France's HAS are conforming to EU directives to reduce diagnostic delays.

Germany's meningitis imaging market is the largest share holder in the Europe. As per the Federal Ministry of Health report in August 2025, €4.4 billion is allocated to the healthcare sector, parts of which includes in the adoption of advanced meningitis imaging technologies. The demand of the region is combined with the expanding patient access and rising neurological disorder incidence, is expected to position Europe as a dominant player in the global meningitis imaging market by 2035.

Meningitis Imaging Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Key Meningitis Imaging Market Players:

    The global meningitis imaging market is very competitive and is fueled by the rising incidence of meningitis cases and advancements in diagnostic imaging technologies. Key players in the market, such as Siemens Healthineers, GE HealthCare, and Canon Medical Systems, are utilizing AI-based imaging tools, cross-functional neurology systems, and integrated diagnostic platforms to gain a competitive edge. Regional expansion, substantial R&D investments, and strategic collaborations are the methods adopted by key players to dominate the meningitis imaging market. Further, startups in the Asia Pacific, mainly in South Korea, Malaysia, and India, are focusing on cost-effective imaging solutions customized for public healthcare systems.

    Here is a list of key players operating in the meningitis imaging market:

    Company Name

    Country of Origin

    Market Share 2025 (%)

    Industry Focus

    GE HealthCare

    U.S.

    13.2%

    AI-powered neuroimaging systems and mobile CT for infectious diseases

    Siemens Healthineers

    Germany

    13.5%

    CNS-targeted MRI and high-speed CT imaging innovations

    Philips Healthcare

    Netherlands

    11.6%

    Integrated PACS systems and brain imaging modules

    United Imaging Healthcare

    China

    5.9%

    Advanced MRI/CT with AI for developing regions

    Mindray Medical

    China

    5.3%

    Portable and economical neuroimaging equipment

    Samsung Medison

    South Korea

    xx%

    Pediatric imaging platforms and 3D neuro-ultrasound

    Medtronic Imaging

    U.S.

    xx%

    AI-assisted neuro-navigation and diagnostics

    Esaote S.p.A

    Italy

    xx%

    Portable MRI and neurology-specific diagnostic tools

    Agfa-Gevaert Group

    Belgium

    xx%

    Diagnostic workflows and meningitis imaging informatics

    NeuroLogica Corporation

    U.S.

    xx%

    Compact mobile CT units for CNS emergencies

    Carestream Health

    U.S.

    xx%

    Low-dose digital imaging for meningitis diagnosis

    Trivitron Healthcare

    India

    xx%

    Budget-friendly neuroimaging for rural diagnostics

    iGene Laboratory Sdn Bhd

    Malaysia

    xx%

    Government-backed neuroimaging and autopsy imaging

    Curatif Imaging Solutions

    Australia

    xx%

    CNS-focused diagnostic platforms for remote clinics

    BPL Medical Technologies

    India

    xx%

    Compact digital X-ray and CT systems

    Canon Medical Systems

    Japan

    xx%

    Pediatric neuroimaging, high-definition CT/MRI platforms

    Fujifilm Healthcare

    Japan

    xx%

    Portable MRI/CT and AI-based neuroimaging

    Hitachi Healthcare

    Japan

    xx%

    Open MRI systems for CNS imaging

    Shimadzu Corporation

    Japan

    xx%

    3D CT scanning platforms for meningitis diagnostics

    Nihon Kohden Imaging

    Japan

    xx%

    Brain function monitoring and neuro-diagnostic systems

    Source: Medicare, EMA, PMDA, MOH, European Commission Health Department

    Below are the areas covered for each company in the meningitis imaging market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Recent Developments

  • In July 2025, NEOSONICS released a portable ultrasound device applying high-frequency sound waves and AI deep learning algorithms for non-invasive detection of infant meningitis. Clinical trials showed sensitivity of 94% and specificity of 95%, significantly reducing the need for lumbar punctures and accelerating infant meningitis diagnosis in resource-limited settings.
  • In January 2025, Siemens Healthineers introduced MAGNETOM Flow MRI which is an AI-based 1.5 Tesla magnetic resonance imaging (MRI) platform. The integration of AI reduces the scan times and improves image quality and resolution.
  • Report ID: 8126
  • Published Date: Sep 25, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In 2026, the industry size of meningitis imaging is evaluated at USD 1.7 billion.

Meningitis Imaging Market size was valued at USD 1.6 billion in 2025 and is projected to reach USD 3.6 billion by the end of 2035, rising at a CAGR of 8.8% during the forecast period, i.e., 2026-2035.

North America is the dominating region in the meningitis imaging market and is projected to hold share of 36.5% by 2035.

Key companies include GE HealthCare, Siemens Healthineers, Philips Healthcare, United Imaging Healthcare, Mindray Medical, Samsung Medison, Medtronic Imaging, Esaote S.p.A, Agfa-Gevaert Group, NeuroLogica Corporation, Carestream Health, Trivitron Healthcare, iGene Laboratory Sdn Bhd, Curatif Imaging Solutions, BPL Medical Technologies, Canon Medical Systems, Fujifilm Healthcare, Hitachi Healthcare, Shimadzu Corporation, Nihon Kohden Imaging.

Meningitis Imaging Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos